comparemela.com
Home
Live Updates
Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes : comparemela.com
Switch from TNF Inhibitors to Biosimilars Provides Consistent Rheumatoid Arthritis Outcomes
A network meta-analysis lends "compelling" support to the practice of switching patients with RA from biologics to less costly biosimilars at 6 months.
Related Keywords
Brazil
,
Sao Paulo
,
Sãpaulo
,
Oliveira Ascef
,
Health Assessment Questionnaire
,
University Of Sao Paulo
,
American College Of Rheumatology
,
Bruna De Oliveira Ascef
,
American College
,
Disability Index
,
comparemela.com © 2020. All Rights Reserved.